JACOBS LEVY EQUITY MANAGEMENT, INC
Position in IRWD — Ironwood Pharmaceuticals Inc
CIK 884414
FLORHAM PARK, NJ
Position in IRWD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,117,708
+$4,367,714 QoQ
Shares Held
4,065,964
+11.9% QoQ
Ownership
2.46%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#14
of 212 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $311,064,443 across 17 Drug Manufacturers - Specialty & Generic names. IRWD ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
726,112 | $122,378,916 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
699,583 | $77,611,738 | |
| 3 | ZTS |
Zoetis Inc.
|
579,079 | $41,612,616 | |
| 4 | LQDA |
Liquidia Corp
|
240,752 | $19,195,156 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
This page
|
4,065,964 | $17,117,708 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
377,085 | $9,242,353 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
199,800 | $5,068,926 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
4,273,026 | $4,871,249 |
All Filings in IRWD
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,117,708 | 4,065,964 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,749,994 | 3,632,477 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,300,077 | 2,759,667 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,515,894 | 1,920,530 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,062,033 | 1,475,046 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,323,070 | 1,580,320 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,050,005 | 3,623,026 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,572,212 | 4,265,100 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $28,416,102 | 4,358,298 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,891,901 | 4,235,580 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,425,282 | 3,009,203 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $22,902,980 | 2,378,295 | Shares | Sole | 2023-11-17 | |
| 2021-06-30 | $541,003 | 42,036 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,136,481 | 280,544 | Shares | Sole | 2021-05-17 | |
| 2020-03-31 | $4,523,165 | 448,282 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||